Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$191M |
| 2 |
Nike
NKE
|
+$190M |
| 3 |
UnitedHealth
UNH
|
+$158M |
| 4 |
Shopify
SHOP
|
+$153M |
| 5 |
TSMC
TSM
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$910M |
| 2 |
Microsoft
MSFT
|
+$668M |
| 3 |
Meta Platforms (Facebook)
META
|
+$351M |
| 4 |
Micron Technology
MU
|
+$244M |
| 5 |
Apple
AAPL
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.86% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Financials | 8.98% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BCYC
1626
Bicycle Therapeutics
BCYC
$273M
| $3.77M | 0.01% |
269,500
-3,100
| -1% | -$66.4K |
|
1627
Dorman Products
DORM
$4.05B
| $3.77M | 0.01% |
29,100
+400
| +1% | +$51.2K |
|
|
ACLX
1628
DELISTED
Arcellx
ACLX
| $3.77M | 0.01% |
+49,100
| New | +$4.24M |
|
1629
James Hardie Industries
JHX
$18B
| $3.76M | 0.01% |
122,127
+3,500
| +3% | +$121K |
|
1630
FlexShares Global Upstream Natural Resources Index Fund
GUNR
$7.04B
| $3.74M | 0.01% |
+102,800
| New | +$4.05M |
|
1631
SiriusPoint
SPNT
$2.76B
| $3.74M | 0.01% |
227,987
+96,687
| +74% | +$1.4M |
|
1632
iShares S&P 100 ETF
OEF
$20.5B
| $3.73M | 0.01% |
12,900
+8,900
| +223% | +$2.55M |
|
1633
Douglas Emmett
DEI
$1.96B
| $3.71M | 0.01% |
199,700
-211,200
| -51% | -$3.94M |
|
|
DOO
1634
Bombardier Recreational Products
DOO
$4.73B
| $3.7M | 0.01% |
72,700
+46,100
| +173% | +$2.4M |
|
1635
iShares MSCI Hong Kong ETF
EWH
$1.21B
| $3.69M | 0.01% |
+221,600
| New | +$3.93M |
|
|
CAN
1636
Canaan Creative
CAN
$171M
| $3.69M | 0.01% |
+1,799,725
| New | +$3.04M |
|
|
LNW
1637
DELISTED
Light & Wonder
LNW
| $3.68M | 0.01% |
42,600
-51,300
| -55% | -$4.81M |
|
1638
Build-A-Bear
BBW
$481M
| $3.68M | 0.01% |
79,877
-84,002
| -51% | -$3.26M |
|
|
DCBO
1639
Docebo
DCBO
$584M
| $3.68M | 0.01% |
82,131
-23,569
| -22% | -$1.11M |
|
1640
Oshkosh
OSK
$9.44B
| $3.67M | 0.01% |
38,600
-84,700
| -69% | -$8.87M |
|
1641
iShares Currency Hedged MSCI EAFE ETF
HEFA
$7.79B
| $3.67M | 0.01% |
105,600
+17,187
| +19% | +$605K |
|
|
PLYM
1642
DELISTED
Plymouth Industrial REIT
PLYM
| $3.67M | 0.01% |
205,911
-30,101
| -13% | -$595K |
|
1643
Alkami Technology
ALKT
$2.21B
| $3.66M | 0.01% |
99,900
+58,157
| +139% | +$2.17M |
|
1644
iShares US Real Estate ETF
IYR
$4.59B
| $3.64M | 0.01% |
39,100
+10,100
| +35% | +$995K |
|
1645
Clearway Energy Class C
CWEN
$7.01B
| $3.64M | 0.01% |
139,900
+60,000
| +75% | +$1.66M |
|
1646
Nektar Therapeutics
NKTR
$2.47B
| $3.64M | 0.01% |
260,719
+38,877
| +18% | +$686K |
|
1647
State Street SPDR Portfolio S&P 500 High Dividend ETF
SPYD
$7.79B
| $3.62M | 0.01% |
83,800
+34,700
| +71% | +$1.57M |
|
1648
Goldman Sachs
GS
$303B
| $3.62M | 0.01% |
6,314
-74,886
| -92% | -$41.8M |
|
1649
State Street Industrial Select Sector SPDR ETF
XLI
$34.8B
| $3.61M | 0.01% |
27,400
-102,500
| -79% | -$14.1M |
|
1650
Tilly's
TLYS
$122M
| $3.61M | 0.01% |
849,012
-35,600
| -4% | -$145K |
|
Similar funds
Jim Simons's Q4 2024 Portfolio in Review
As of Q4 2024, Jim Simons held 4,032 positions worth $67.6B, up 1.6% from $66.5B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Jim Simons's Q4 2024 filing shows 548 new, 1,485 increased, 1,480 reduced and 497 closed positions. Its largest new stake was UnitedHealth: 278,658 shares worth $141M. The largest sale was Palantir, an estimated $910M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2024 buy was UnitedHealth: 278,658 shares worth $141M.
- Jim Simons added most to Alibaba in Q4 2024, an estimated $191M increase.
- Jim Simons's biggest Q4 2024 reduction was Palantir, cutting an estimated $910M.
- Jim Simons fully exited Arm in Q4 2024, selling an estimated $153M.
- Jim Simons's ten largest holdings make up 10% of its $67.6B portfolio in Q4 2024.
- Jim Simons opened 548 new positions and closed 497 in Q4 2024.
- Jim Simons's portfolio value rose 1.6% quarter-over-quarter to $67.6B.
Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.